Wong Alvin F 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Wong Alvin F
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-03-03+44,882→ 62,034 total - Award
Stock Option (Right to Buy)
2022-03-03+64,118→ 64,118 totalExercise: $2.33Exp: 2032-03-02→ Common Stock (64,118 underlying)
Footnotes (2)
- [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024
- [F2]Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.